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Abstract
Background: Atrial fibrillation (AF) is the most common arrhythmia. The potassium current IKs is essential for
cardiac repolarization. Gain-of-function mutations in KV7.1, the pore-forming a-subunit of the IKs channel, have
been associated with AF. We hypothesized that early-onset lone AF is associated with mutations in the IKs channel
regulatory subunit KCNE1.
Methods: In 209 unrelated early-onset lone AF patients (< 40 years) the entire coding sequence of KCNE1 was
bidirectionally sequenced. We analyzed the identified KCNE1 mutants electrophysiologically in heterologous
expression systems.
Results: Two non-synonymous mutations G25V and G60D were found in KCNE1 that were not present in the
control group (n = 432 alleles) and that have not previously been reported in any publicly available databases or in
the exom variant server holding exom data from more than 10.000 alleles. Proband 1 (female, age 45, G25V) had
onset of paroxysmal AF at the age of 39 years. Proband 2 (G60D) was diagnosed with lone AF at the age of 33
years. The patient has inherited the mutation from his mother, who also has AF. Both probands had no mutations
in genes previously associated with AF. In heterologous expression systems, both mutants showed significant gain-
of-function for IKs both with respect to steady-state current levels, kinetic parameters, and heart rate-dependent
modulation.
Conclusions: Mutations in KV7.1 leading to gain-of-function of IKs current have previously been described in lone
AF, yet this is the first time a mutation in the beta-subunit KCNE1 is associated with the disease. This finding
further supports the hypothesis that increased potassium current enhances AF susceptibility.
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Background
Atrial fibrillation (AF) is the most prevalent sustained
cardiac arrhythmia. It is responsible for considerable
morbidity and mortality, and its population prevalence
has reached epidemic proportions, affecting almost
seven million patients in the European Union and the
USA combined [1-4].
In most cases AF is associated with cardiac risk factors
such as hypertensive, ischemic, and/or structural heart
disease [1,5]. However, 10-20% of patients suffering
from AF are younger than 60 years of age and lack the
traditional risk factors for AF. These patients are consid-
ered as having “lone” AF [2]. The mechanisms underly-
ing AF are not fully understood, but a heterogeneous
model based on the interaction of multiple substrates
and triggers is thought to underlie the pathophysiology
of the disease. However, early-onset lone AF has been
suggested to be a primary electrical disease caused by
disturbances in ionic currents. Of note, a genetic cause
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increasingly recognized [6].
Identification of the genetic components of AF, and
the importance of single nucleotide polymorphisms
(SNPs) was recently shown in genome-wide association
studies indicating that common variants also play a role
in the development of AF [7,8]. This association
between SNPs and AF was strongest in patients diag-
nosed at a younger age. There is evidence that variations
in genes encoding ion channel subunits are associated
with familial predisposition for AF. Several genetic
reports have revealed mutations associated with AF in
cardiac ion channels and accessory subunits [6]. Most of
these studies show that gain- or loss-of-function muta-
tions in the genes encoding proteins contributing to car-
diac depolarization, e.g. SCN1-3B (involved in INa) [6,9],
or cardiac repolarisation, e.g. KCNQ1 (IKs), KCNH2
(IKr), KCNJ2 (IK1) can lead to increased susceptibility to
AF [6]. These results support the two current concep-
tual models for AF. The first one being that cardiac
action potential shortening functions as a substrate for
re-entry wavelets in the atria [10,11] the second one
proposing that a prolonged effective refractory period
e n h a n c e st h ep r o p e n s i t yf o re a r l ya f t e rd e p o l a r i z a t i o n ,
and thereby increasing the susceptibility to AF [12].
KV7.1, the a-subunit of the IKs current, has repeatedly
been associated with AF [6]. Co-expression of its regula-
tory b-subunit KCNE1 changes the biophysical proper-
ties of the KV7.1 channel dramatically [13]. We
hypothesized that early-onset lone AF is associated with
mutations in KCNE1.
Methods
An expanded Methods section is available in Additional
file 1.
Study subjects
Consecutive patients with lone AF and onset of AF
before 40 years (i.e. absence of clinical or echocardio-
graphic findings of other cardiovascular diseases, hyper-
tension, metabolic or pulmonary diseases) were included
from eight hospitals in the Copenhagen region of Den-
mark [9]. Healthy controls (216) were recruited from
blood donors. The study conforms to the principles out-
lined in the Declaration of Helsinki and was approved
by the Scientific Ethics Committee of Copenhagen and
Frederiksberg (Protocol reference number KF
01313322). All included patients gave written informed
consent.
Mutation screening
Genomic DNA was extracted from blood samples using
the QIAamp DNA Blood Mini Kit (QIAGEN, Hilden,
Germany). Oligonucleotide primers for exons and splice
junctions were designed using the known sequence of
human KCNE1 [Genbank:NG_009091.1]. All primers
were designed with M13 tail sequences. DNA fragments
amplified by Touchdown PCR were analyzed using a
high-resolution melting curve analysis (Light Scanner,
Idaho Technology, UT, USA). Fragments with melting
curves differing from the curves of wild-type DNA were
purified and directly sequenced using M13 primers and
Big Dye chemistry (DNA analyzer 3730, Applied Biosys-
tems, CA, USA). The identified variants were validated
by the resequencing of a second PCR product.
A group of 216 ethnically matched healthy controls
was screened employing high resolution melting curve
analysis (Light Scanner, Idaho technology, Salt Lake
City, USA), and bidirectional sequencing of genes pre-
viously associated with AF was performed (Additional
file 1). A mutation was considered suspected being dis-
ease causing if criteria previously defined were met [9].
Molecular biology
Site-directed mutagenesis introducing the mutations
G25V (c.74 C > T) and G60D (c.179 G > A) into
human KCNE1 cDNA [Genbank:NM_000219.3] and in
vitro transcription were performed using standard pro-
cedures. For a detailed description please refer to the
Additional file 1.
Heterologous expression studies
We employed two-electrode voltage-clamp experiments
using Xenopus laevis oocytes expressing wild-type or
mutant IKs and patch-clamp experiments using mamma-
lian cells. A detailed description is available in Addi-
tional file 1.
Data analysis
Data analysis was performed with Igor Pro (Wave-
metrics, Lake Oswego, OR, USA) and GraphPad Prism
(GraphPad Software Inc., San Diego, CA, USA). I/V-
curves were constructed by measuring the current at the
end of a voltage-step to potentials ranging from -100 to
+60 mV for TEVC recordings or +40 mV for patch-
clamp experiments, respectively. The data was plotted
against the corresponding membrane potentials. Simi-
larly, peak tail-currents, measured at -120 mV for TEVC
or -40 mV for patch-clamping experiments following
the depolarizing step, were plotted against the mem-
brane potential of the depolarizing step to construct the
activation curves. A Boltzmann function (I/Imax = Imin +
(Imax-Imin)/(1 + exp((V50-V)/k))) was fitted to the activa-
tion curves to obtain the potential of half-maximal acti-
vation (V50) and the slope factor (k). Activation of
KV7.1/KCNE1 channels results in sigmoidal activation
current traces. In order to compare the activation
kinetics we determined the time needed to reach the
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values of the time constants of channel deactivation (τ)
was obtained by fitting a mono-exponential function to
tail-current traces measured at -140 to -40 mV following
a voltage-step to +40 mV for TEVC or 0 mV for patch-
clamp experiments.
The frequency dependence of conduction was investi-
gated using three different voltage protocols (60, 120,
and 180 bpm). The amount of charge conducted by the
IKs channel complex was calculated by integrating the
area under the curve in the first 130 ms after the capaci-
tive spike (10 ms) of the pulse at the 7th second. At this
time point the current amplitude had reached a steady-
state for all pacing frequencies tested. The amount of
charge carried was normalized to the charge carried at
60 bpm.
Data are represented as mean ± SEM, unless other-
wise indicated. Unpaired t-tests or ANOVA followed by
Tukey’s method of multiple comparisons were used as
appropriate to compare the wild-type and mutated IKs
channel complex. P-values below 0.05 were considered
statistically significant.
A detailed description of all methods used is available
in Additional file 1.
Results
Study cohort
The study population consisted of 209 patients with
onset of AF ranging from 16 to 39 years, without any
concomitant disease. A control population of 216
healthy blood donors was collected (52% male gender,
median age of 39 years (interquartile range 30-48
years)). Healthy controls were included after clinical eva-
luation and ECG recording. All included individuals
were of Danish/Caucasian ethnicity. Clinical data of the
study population is shown in Table 1[14].
Mutation screening
Direct DNA sequencing of KCNE1 from the 209 index
patients revealed two non-synonymous mutations in
KCNE1 (c.74 g > t, G25V; c.179 G > A, G60D) (Figure
1). The mutations were not present in the control group
(n = 216), and have not previously been reported to be
associated with AF. All genetically affected probands
were heterozygous carriers. The positions G25 and G60
in KCNE1 are highly conserved across species suggest-
ing a functional importance (Additional file 1: Figure
S1).
Clinical data
Proband 1 (female, age 45) was diagnosed with paroxys-
mal AF at the age of 39 years. The sinus rhythm ECG
showed an incomplete right bundle branch block
(IRBBB; defined as an extra r’-wave in lead V1 and/or
V2 [15]) but was otherwise normal (QTc 401 ms) (data
not shown). She had a normal echocardiography, and
there was no history of AF in her family.
Proband 2 (male, age 45) had experienced distinct pal-
pitations since the age of 20 years and AF was docu-
mented by ECG at the age of 33 years. At inclusion, he
experienced weekly palpitations and chest discomfort
lasting from one hour to half a day. The frequency of
AF was higher during periods of physiological stress.
The patient had a sinus rhythm ECG with IRBBB and a
borderline long QTc interval where borderline pro-
longed in males is defined as QTc 440-460 ms [16] (Fig-
ure 1C: P-wave 80 ms, PR 116 ms, QRS 114 ms, QTc
457 ms). There was no sign of hypertrophy or ischemia
in the ECG and echocardiography was normal. He never
experienced syncope or near-syncope. For clinical pur-
pose, the patient had an implantable loop recorder
inserted for one year. The device revealed that the
patient had AF 6% of the time and no ventricular
arrhythmias were detected during the observation per-
iod. The patient’s mother (I-3, Figure 1D) was diagnosed
with paroxysmal AF and had palpitations since the age
of 28 years. She also had a borderline long QTc interval
of 459 ms and carries the mutation G60D in KCNE1.
The proband’s uncle (I-2) has a history of palpitations
and chest discomfort, but was unavailable for genetic
screening.
Both index patients were free of mutations in genes
previously associated with AF (KCNQ1, KCNH2,
KCNN3, KCNA5, KCNE2/3/5, KCNJ2,5, SCN5A, SCN1-
3B, ANP, and LMNA).
KCNE1-G25V and KCNE1-G60D cause gain-of-function of IKs
The slow delayed rectifier potassium current IKs is
important for terminating the cardiac action potential
a n di sc o m p o s e do fK V7.1 and KCNE1 [17,18]. To
Table 1 Clinical characteristics of the lone AF population
(n = 209)
Median age of onset, y (IQR) 31.5 (26-36)
Male gender, % 82
Height, cm 183 ± 9
Weight, kg 89 ± 17
BMI, kg/m
2 26.7 ± 4.6
Blood Pressure, mmHg
Systolic 131 ± 13
Diastolic 78 ± 9
AF type
Paroxysmal, % 55.9
Persistent, % 35.9
Permanent, % 8.2
Family history of AF
1
st degree relatives with AF, % 31
All numbers are reported as mean ± standard-deviation unless otherwise
noted. IQR Interquartile range.
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KCNE1 could explain the lone AF phenotype observed
in the proband, we expressed wild-type (WT) or mutant
KCNE1 together with the pore forming KV7.1 a-subunit
in X.laevis oocytes and recorded currents using the two-
electrode voltage-clamp technique.
Expression of KV7 . 1a n dK C N E 1g a v er i s et oas l o w l y
activating and deactivating potassium current, that does
not inactive (Figure 2A). Co-expression of the mutants
KCNE1-G25V or KCNE1-G60D and KV7.1 (Figure 2B,
Additional file 1: Figure S2) resulted in larger current
amplitudes compared to the WT complex.
When summarizing the current measurements from
oocytes expressing either KCNE1-WT, KCNE-G25V or
KCNE-G60D together with KV7.1, subjected to 5 s
depolarizing potentials from a holding potential of -80
mV we found that both mutations caused an increase in
steady-state current amplitude at all activating potentials
(Figure 2C, Additional file 1: Figure S2). Voltage-depen-
dence of channel activation determined by tail-current
analysis did not reveal any difference between KCNE1-
WT and mutants (Figure 2D, Additional file 1: Figure
S2).
The KCNE1 mutations also altered biophysical prop-
erties as visible from the current traces in Figure 2.
Activation of KV7.1/KCNE1 channels results in sigmoi-
dal activation current traces [19]. To compare the
activation kinetics we determined the time needed to
reach the half-maximal current level (t1/2) when currents
were elicited at physiologically relevant potentials 0 and
+20 mV. The activation was significantly faster for the
mutated channels as compared with wild-type channels
(Figure 2E, Additional file 1: Figure S2).
Deactivation kinetics were investigated by recording
tail-currents at potentials ranging from -140 to -40 in
20 mV increments after an activating step to +40 mV
(Figure 3A, B). The deactivating current traces were best
fitted to a single exponential function. The summarized
data in Figure 3C shows that expression of KCNE1-
G60D resulted in a significantly faster deactivation when
investigated at -100 and -120 mV. For KCNE1-G25V,
deactivation kinetics were similar to WT (data not
shown).
Faster activation kinetics suggests a gain-of-function in
IKs whereas the opposite is true for the observed
changes in deactivation kinetics. In the following, we
focused on the functional characterization of G60D due
to the more complex electrophysiological phenotype and
due to the history of AF in this family. To address
whether the changed channel kinetics of the mutant
would result in altered heart rate-dependent modulation
of IKs, protocols mimicking heart rates of 60, 120, and
180 bpm were used. When X.laevis oocytes were sub-
jected to voltage protocols at 60 bpm no accumulation
Figure 1 Clinical characterization and genetic analysis of probands. A: DNA sequence analysis. B: Positions of mutations indicated in
schematic of protein topology. C: ECG from proband 2 (paper speed 25 mm/s, 1 mV/mm). D: Pedigree of the family with the novel KCNE1
G60D mutation. Squares: male, circles: female family members, respectively. Arrow indicates the proband 2. Solid black symbols indicate the
presence of AF, open symbols: unaffected members, gray: AF history; (+/-): presence of the heterozygous mutation for persons with DNA
samples available for testing.
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tion” at 120 and 180 bpm resulted in an accumulation
of IKs current which reached significance for 180 bpm
(see Figure 4). The amount of charge conducted by
KV7.1/KCNE1-WT (n = 10) or KV7.1/KCNE1-G60D (n
= 15) channels in the first 130 ms after the capacitive
spike of the pulse at the 7th second was calculated and
normalized to the charge carried at 60 bpm (Figure 4).
The frequency-dependent buildup of conducted charge
was significantly larger in the mutated IKs channel com-
plex as compared to WT when measured at 180 bpm.
To mimic the heterozygote state of the affected sub-
jects we co-expressed KV7.1 with KCNE1-WT and
KCNE1-G60D. This resulted in an intermediate pheno-
type both with respect to current amplitudes and
channel kinetics. Activation kinetics were not signifi-
cantly different from KV7.1/KCNE1 channels, but deac-
tivation kinetics were significantly faster for the
heterozygote state as compared to wild-type channels
when measured at -120 to -80 mV (Additional file 1:
Figure S3).
To verify the findings from the two-electrode voltage-
clamp experiments, we performed whole cell patch-
clamp experiments in CHO-K1 cells (Figure 5) at 36 ±
1°C. Under these conditions the expression of KV7.1 and
KCNE1 resulted in a non-inactivating KV7.1/KCNE1
current with marked faster activation and deactivation
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Figure 2 Comparison of IKs-WT and IKs-G60D channel currents.
Representative current traces for KCNE1-WT (A) and KCNE1-G60D
(B) channel subunits co-expressed with KV7.1 in X.laevis oocytes in a
1:1 molar ratio. Current step protocol is shown as inset. C: I/V
relationship for IKs-WT (n = 21) and IKs-G60D (n = 23) as determined
from peak currents (open and filled squares). D: Voltage-
dependence of IKs-WT and IKs-G60D channel activation as
determined from tail currents (open and filled circles). E: Activation
rise time, determined as the time to 1/2 max following a
depolarization to 0 mV or +20 mV.
Figure 3 Comparison of IKs-WT and IKs-G60D channel
deactivation. KCNE1-WT (A) and KCNE1-G60D (B) channel subunits
co-expressed with KV7.1 in X.laevis oocytes in a 1:1 molar ratio.
Current step protocol is shown as inset. (C) Enlargement of the tail-
currents normalized to maximum current amplitude (gray: IKs-WT;
black: IKs-G60D). Deactivation time constants (tau) were obtained by
fitting the tail-current traces to a mono-exponential function (D).
Figure 4 Frequency dependence of conduction. Three different
voltage protocols were applied (60 bpm (+20 mV for 200 ms,
followed by 800 ms at -80 mV); 120 bpm (+20 mV for 180 ms,
followed by 320 ms at -80 mV); 180 bpm (+20 mV for 150 ms,
followed by 180 ms at -80 mV)). The bar graph summarizes the
amount of charge conducted by KV7.1-WT/KCNE1 (black; n = 10) or
KV7.1/KCNE1-G60D (white; n = 15) channels in the first 130 ms after
the capacitive spike (10 ms) of the pulse at the 7th second when
normalized to the charge carried at 60 bpm. Representative current
traces recorded (left: KV7.1/KCNE1; right: KV7.1/KCNE1-G60D) using
the 60 bpm (black) and 120 bpm (gray) protocols are shown on the
right.
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expressed in X.laevis oocytes. In the mammalian expres-
sion system we observed no significant difference
between the wild-type and mutated IKs channel complex
with respect to steady-state current amplitude or vol-
tage-dependence of channel activation. However, the
activation time was still significantly faster when the
mutated b-subunit was expressed together with KV7.1.
No significant difference in deactivation kinetics was
observed between WT and mutant (Figure 6).
Discussion
Although AF is the most common cardiac arrhythmia,
the fundamental molecular pathways in many cases
remain undefined. To our knowledge, the present study
is the first to report that mutations in the b-subunit
KCNE1 are associated with AF.
Both mutations (G25V, G60D) were absent in 216
matched controls, in publicly available databases and in
2276 exoms from the Popgen population NHLBI Exome
Sequencing Project http://evs.gs.washington.edu/EVS/
supporting that these variants are not rare polymorph-
isms but disease causing mutations [20]. The patient
carrying mutation G25V had no family history of
arrhythmia. The patient carrying mutation G60D had an
interesting phenotype of AF and borderline QTc interval
that co-segregated from the mother to the son.
We used the Xenopus laevis oocyte system as it allows
for better control of subunit ratios compared to trans-
fection of mammalian cell lines such as CHO-K1. In X.
laevis oocytes, KCNE1-G25V and KCNE1-G60D showed
a gain-of-function for IKs both with respect to steady-
state current levels, kinetics, and heart rate-dependent
modulation of IKs (for G60D). When investigating the
mutation in an experimental condition mimicking the
heterozygous state of the patient, changes were not sig-
nificant and hence the functional studies did not fully
explain the phenotype, which could indicate that either
the mutation is not causing the phenotype, or that the
interaction is more complex. Yet, we showed gain-of-
function effects for both identified mutations strength-
ening the notion that mutations in KCNE1 are asso-
ciated with AF.
Furthermore, it has been shown that monoallelic
expression is much more widespread than previously
thought affecting 20% of human genes [21]. In a study
addressing 190 genes on chromosome 21, KCNE1 was
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Figure 5 Comparison of IKs-WT and IKs-G60D channel currents
at 37°C. KCNE1-WT (A) and KCNE1-G60D (B) channel subunits co-
expressed with KV7.1 in CHO cells. Current protocol shown as inset.
C: I/V relationship for IKs-WT (n = 15) and IKs-G60D (n = 12). Currents
were measured at the end of the 2-second test pulse (open and
filled squares) and normalized to cell size. D: Voltage-dependence of
IKs-WT and IKs-G60D channel activation. Peak tail-currents were
measured at -40 mV (open and filled circles), and the normalized
data were fit to a two-state Boltzmann distribution. E: Activation rise
time, determined as the time to 1/2 max following a depolarization
to 0 or +20 mV.
Figure 6 Comparison of IKs-WT and IKs-G60D channel
deactivation kinetics. KCNE1-WT (A) and KCNE1-G60D (B) channel
subunits co-expressed with KV7.1 in CHO cells. Currents were
elicited by clamping the cells for 2 s at 0 mV, followed by a 1 s step
to test potentials ranging from -100 to -20 mV in 20 mV increments,
at 36 ± 1°C. (C) Enlargement of the tail-currents normalized to
maximum current amplitude (gray: IKs-WT; black: IKs-G60D).
Deactivation time constants (tau) were obtained by fitting the tail-
current traces to a mono-exponential function (D).
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KCNE1 a profoundly epigenetically regulated gene [22]
thereby making also the homozygote experimental con-
dition highly relevant.
Though differences were less pronounced in mamma-
lian cells, we still observed a gain-of-function of activa-
tion kinetics for G60D. Mutations leading to even mild
gain-of-function of the IKs current have been described
earlier in the context of lone AF, yet all mutations iden-
tified so far reside in the a-subunit of the channel com-
plex [18,23]. Two studies have investigated a possible
association between AF and the SNP G38S in the b-sub-
unit KCNE1 in Chinese AF cohorts. Lai et al. reported a
significant association of 38 G, which was not found in
the later study [24,25]. Of note, others observed
decreased IKs amplitudes and reduced surface expression
with 38 G pointing to a loss-of-function of this variant
[26].
The mutation G25V is located in the extracellular N-
terminus of the channel protein. A recent study as
implicated the extracellular juxtamembranous region of
KCNE1 in gating [27], however, little is known about
the role of the proximal KCNE1 N-terminus. The muta-
tion G60D resides in the transmembrane segment
(TMS) of KCNE1 in close proximity of residues 57-59
("the gating triplet”) that are critical for the modulation
of KV7.1 channels [28]. Several glycine residues located
in the TMS including G60 seem instrumental for form-
ing a curvature that locates threonine 58 [29], which is
critical for slow activation kinetics conferred by KCNE1
[30]. Hence, the mutation G60D in this close proximity
could be speculated to compromise the function of this
critical amino acid and thereby speed up activation
[30-33].
Gain-of-function mutations of the IKs channel are
expected to increase the repolarising potassium currents
which could abbreviate the cardiac action potential
duration as well as the effective refractory period in car-
diomyocytes. The mutation could thereby create a profi-
brillatory substrate within the atrium [10,11]. IKs also
plays a major role in ventricular repolarization. Gain-of-
function of IKs w o u l db ee x p e c t e dt or e s u l ti nb o t h
action potential and QTc shortening which we did not
observe in the proband. It has been suggested that com-
mon variations in other genes may protect the patient
from a shortening of QTc [31]. All mutation carriers in
this study had not experienced ventricular arrhythmias,
yet display a borderline long QTc interval. Pai and Raw-
les suggested a link between AF and prolongation of the
mean QT interval [32]. The first study associating gain-
of-function mutations in KV7.1 with AF analyzed a large
four-generation family. Nine of 16 family members diag-
nosed with autosomal dominant hereditary AF showed
prolonged QTc ranging from 450 to 530 ms [33]. Vice
versa, Ackermann and colleagues reported presence of
early-onset AF in a cohort of congenital LQT patients
underlining the evidence for a link between these two
syndromes [34]. Very recently, also a Brugada syndrome
associated gain-of-function mutation in KV4.3, the a-
subunit underlying the transient outward current Ito, has
been linked with QTc prolongation in the affected family
member [35].
Despite the fact that proband 2 and his mother, both
carrying the mutation G60D, had borderline long QTc
intervals, there was no further suspicion of LQTS in the
two patients. Clinical evaluation revealed no family his-
tory of syncope or near-syncope and the proband had a
one year implantable loop recorder without any ventri-
cular arrhythmias detected. Of note, both our index pro-
bands had an ECG pattern of IRBBB, which has recently
been shown to be associated with early-onset lone AF
[15] supporting the AF phenotype in the patients.
The exact mechanisms linking AF and QT prolonga-
tion and the different effect of IKs mutations remain to
be elucidated. One possible explanation may be different
composition of the IKs channel complex in atria and
ventricles as suggested earlier to explain a mixed pheno-
type of AF and QT prolongation in a patient with a
KCNQ1 mutation [18]. Also, chamber-specific interac-
tion partners yet to be identified may modulate the
effects of mutations in atria and ventricles. Furthermore,
differences in triggers such as the well-documented
beta-adrenergic stimulation [36] or the more recently
described modulation by natriuretic peptide precursor A
may be involved [23,37].
Limitations
We limited our analysis to the KCNE1 encoding regions,
and the possibility of mutations occurring in regions of
the gene other than coding regions cannot be excluded.
Though we performed genetic testing of all genes asso-
ciated with AF earlier, we cannot exclude mutations in
yet unknown genes. Furthermore, genetic testing of
family members was limited as some were unavailable.
Also, the number of probands was small, however, it
should be noted that the cohort of young lone AF
patients was well-defined. The functional analyses used
conventional heterologous expression systems in which
t h ee n v i r o n m e n t sd i f f e rf r o mt h a ti nt h en a t i v e
cardiomyocytes.
Conclusions
In this study of lone AF patients, we found two sus-
pected disease-causing mutations in KCNE1. Functional
analysis of G25V and G60D showed a gain-of-function
of the IKs current. This study supports the hypothesis
that gain-of-function in potassium current enhances AF
susceptibility.
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